Updates are available Correction dated 2022-04-28
Click to view Correction: https://doi.org/10.1186/s12884-022-04695-y
-
Authors
Esposito, Giovanna
Mauri, Paola Agnese
Cipriani, Sonia
Franchi, Matteo
Corrao, Giovanni
Parazzini, Fabio
- License Information
-
More Information
Article History
Received: 13 September 2021
Accepted: 28 February 2022
First Online: 22 March 2022
Change Date: 28 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12884-022-04695-y
Declarations
:
: This analysis is exempt from IRB authorization and informed consent (according to General Authorization for the Processing of Personal Data for Scientific Research Purposes issued by the Italian Privacy Authority on December 15, 2016;ExternalRef removed). Data and permission for the analysis were obtained by the Regional Health Authorities of Lombardy, Italy.
: Not applicable.
: Giovanni Corrao received research support from the European Community (EC), the Italian Agency of Drugs (AIFA), and the Italian Ministry for University and Research (MIUR). He took part in a variety of projects that were funded by pharmaceutical companies (i.e. Novartis, GSK, Roche, AMGEN and BMS). He also received honoraria as a member of the advisory board to Roche. The other authors declare that they have no conflicts of interest to disclose.
